Emergent Biosolutions Company Profile (NYSE:EBS)

About Emergent Biosolutions

Emergent Biosolutions logoEmergent BioSolutions Inc. is a biopharmaceutical company that offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company develops, manufactures and delivers a portfolio of medical countermeasures primarily for government agencies in the areas of biological and chemical threats and emerging infectious diseases (EID). It also develops and commercializes therapeutics in areas of hematology/oncology, transplantation, infectious diseases and autoimmune disorders. Its two operating divisions include Biodefense and Biosciences. The Biodefense division is a pharmaceutical business focused on countermeasures that address public health threats, including chemical, biological, radiological, nuclear and explosives (CBRNE) threats, as well as EID. The Biosciences division is a pharmaceutical business focused on therapeutics in hematology/oncology with secondary on transplantation, infectious disease and autoimmunity.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NYSE
  • Symbol: EBS
  • CUSIP: 29089Q10
Key Metrics:
  • Previous Close: $28.36
  • 50 Day Moving Average: $27.61
  • 200 Day Moving Average: $34.28
  • 52-Week Range: $40,458,000.00 - $26.12
  • Trailing P/E Ratio: 20.29
  • Foreward P/E Ratio: 14.04
  • P/E Growth: 1.25
  • Market Cap: $1.15B
  • Outstanding Shares: 40,458,000
  • Beta: 1.24
Profitability:
  • Net Margins: 11.61%
  • Return on Equity: 11.93%
  • Return on Assets: 7.56%
Debt:
  • Debt-to-Equity Ratio: 0.37%
  • Current Ratio: 5.08%
  • Quick Ratio: 4.15%
Additional Links:
Companies Related to Emergent Biosolutions:

Analyst Ratings

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)
Ratings Breakdown: 1 Hold Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: $39.00 (39.63% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)
Show:
DateFirmActionRatingPrice TargetDetails
8/7/2016Cowen and CompanyReiterated RatingHold$33.00View Rating Details
8/5/2016JPMorgan Chase & Co.Lower Price TargetOverweight$45.00 -> $36.00View Rating Details
6/28/2016Singular ResearchLower Price TargetBuy$44.00 -> $40.00View Rating Details
6/22/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
5/2/2016Chardan CapitalReiterated RatingBuyView Rating Details
3/6/2015Summer StreetReiterated RatingBuy$35.00View Rating Details
(Data available from 9/26/2014 forward)

Earnings

Earnings History for Emergent Biosolutions (NYSE:EBS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q2($0.17)($0.18)$111.20 million$101.49 millionViewListenView Earnings Details
5/5/2016Q1($0.07)$0.16$101.83 million$111.00 millionViewListenView Earnings Details
2/25/2016Q4$0.70$0.78$168.07 million$168.10 millionViewListenView Earnings Details
11/5/2015Q315$0.55$0.83$151.42 million$164.90 millionViewListenView Earnings Details
8/6/2015Q215$0.18$0.36$114.25 million$126.10 millionViewListenView Earnings Details
5/7/2015Q1($0.45)($0.50)$62.70 million$63.60 millionViewListenView Earnings Details
3/5/2015Q115$0.69$0.75$147.00 million$148.00 millionViewListenView Earnings Details
11/6/2014Q414$0.52$0.49$126.90 million$138.00 millionViewListenView Earnings Details
8/7/2014Q214$0.32$0.25$109.25 million$110.30 millionViewListenView Earnings Details
5/8/2014Q114($0.14)($0.55)$57.30 million$53.90 millionViewListenView Earnings Details
3/6/2014Q413$0.36$0.42$93.83 million$94.10 millionViewListenView Earnings Details
11/7/2013Q313$0.21$0.37$79.13 million$89.10 millionViewListenView Earnings Details
8/5/2013Q2 2013$0.21$0.29$75.73 million$82.40 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.14)($0.22)$46.17 million$43.10 millionViewListenView Earnings Details
3/7/2013Q4 2012$0.44$0.44$95.09 million$94.61 millionViewListenView Earnings Details
11/1/2012Q312$0.22$0.18$73.53 million$66.60 millionViewN/AView Earnings Details
8/2/2012$0.21$0.21ViewN/AView Earnings Details
5/3/2012($0.18)($0.19)ViewN/AView Earnings Details
3/8/2012$0.72$0.78ViewN/AView Earnings Details
11/3/2011($0.04)$0.04ViewN/AView Earnings Details
8/4/2011$0.33$0.40ViewN/AView Earnings Details
5/5/2011($0.52)($0.64)ViewN/AView Earnings Details
3/10/2011$0.67$0.76ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Emergent Biosolutions (NYSE:EBS)
Current Year EPS Consensus Estimate: $1.03 EPS
Next Year EPS Consensus Estimate: $1.99 EPS

Dividends

Dividend History for Emergent Biosolutions (NYSE:EBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Emergent Biosolutions (NYSE:EBS)
Insider Ownership Percentage: 17.20%
Institutional Ownership Percentage: 89.95%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/6/2016George A JoulwanDirectorSell4,700$44.12$207,364.00View SEC Filing  
6/1/2016Daniel Abdun-NabiCEOSell8,699$43.74$380,494.26View SEC Filing  
5/27/2016Fuad El-HibriMajor ShareholderSell9,835$43.50$427,822.50View SEC Filing  
5/26/2016Fuad El-HibriMajor ShareholderSell39,759$43.13$1,714,805.67View SEC Filing  
5/25/2016Fuad El-HibriMajor ShareholderSell85,000$42.52$3,614,200.00View SEC Filing  
5/25/2016Zsolt HarsanyiDirectorSell27,867$42.33$1,179,610.11View SEC Filing  
5/24/2016Fuad El-HibriChairmanSell20,000$42.26$845,200.00View SEC Filing  
5/23/2016Fuad El-HibriChairmanSell45,000$42.62$1,917,900.00View SEC Filing  
5/20/2016Daniel Abdun-NabiCEOSell8,701$42.00$365,442.00View SEC Filing  
5/19/2016Jerome M HauerDirectorSell3,134$41.22$129,183.48View SEC Filing  
5/13/2016Louis W SullivanDirectorSell47,631$39.21$1,867,611.51View SEC Filing  
5/12/2016Fuad El-HibriMajor ShareholderSell25,000$38.71$967,750.00View SEC Filing  
5/12/2016Jerome M HauerDirectorSell4,700$38.50$180,950.00View SEC Filing  
5/11/2016Louis W SullivanDirectorSell9,969$39.25$391,283.25View SEC Filing  
4/22/2016Fuad El-HibriMajor ShareholderSell4,209$40.50$170,464.50View SEC Filing  
4/18/2016Daniel Abdun-NabiCEOSell8,702$40.17$349,559.34View SEC Filing  
4/18/2016Fuad El-HibriMajor ShareholderSell20,791$40.50$842,035.50View SEC Filing  
4/6/2016Fuad El-HibriMajor ShareholderSell50,000$39.00$1,950,000.00View SEC Filing  
4/6/2016Robert KramerEVPSell21,786$38.90$847,475.40View SEC Filing  
4/4/2016Robert KramerEVPSell21,788$36.90$803,977.20View SEC Filing  
4/1/2016Robert KramerEVPSell43,572$35.56$1,549,420.32View SEC Filing  
3/14/2016Adam HaveyEVPSell4,359$33.96$148,031.64View SEC Filing  
3/14/2016Jerome M HauerDirectorSell2,350$33.88$79,618.00View SEC Filing  
3/11/2016Adam HaveyEVPSell11,112$33.84$376,030.08View SEC Filing  
3/11/2016Louis W SullivanDirectorSell14,879$34.03$506,332.37View SEC Filing  
3/7/2016Marvin L WhiteDirectorSell33,134$35.42$1,173,606.28View SEC Filing  
1/4/2016Sue BaileyDirectorSell11,520$38.79$446,860.80View SEC Filing  
12/30/2015Ronald RichardDirectorSell21,600$40.00$864,000.00View SEC Filing  
12/24/2015Daniel Abdun-NabiCEOSell63,209$39.06$2,468,943.54View SEC Filing  
11/19/2015Fuad El-Hibrimajor shareholderSell17,871$37.50$670,162.50View SEC Filing  
11/13/2015Fuad El-Hibrimajor shareholderSell13,013$36.50$474,974.50View SEC Filing  
11/12/2015Barry LabingerEVPSell36,126$35.64$1,287,530.64View SEC Filing  
11/9/2015Fuad El-Hibrimajor shareholderSell13,225$35.50$469,487.50View SEC Filing  
11/6/2015Fuad El-Hibrimajor shareholderSell13,450$34.50$464,025.00View SEC Filing  
11/3/2015Fuad El-Hibrimajor shareholderSell13,689$33.50$458,581.50View SEC Filing  
9/11/2015Sue BaileyDirectorSell6,080$32.37$196,809.60View SEC Filing  
8/13/2015George A JoulwanDirectorSell7,200$34.72$249,984.00View SEC Filing  
7/20/2015Fuad El-HibriChairmanSell234$34.50$8,073.00View SEC Filing  
7/13/2015Ronald RichardDirectorSell4,922$34.00$167,348.00View SEC Filing  
6/29/2015Ronald RichardDirectorSell4,923$32.76$161,277.48View SEC Filing  
6/22/2015Fuad El-HibriMajor ShareholderSell74,564$32.60$2,430,786.40View SEC Filing  
6/16/2015Louis W SullivanDirectorSell13,457$31.33$421,607.81View SEC Filing  
6/15/2015Adam HaveyEVPSell36,298$31.55$1,145,201.90View SEC Filing  
6/15/2015Fuad El-HibriMajor ShareholderSell45,436$32.18$1,462,130.48View SEC Filing  
1/20/2015Fuad El-HibriMajor ShareholderSell15,325$27.67$424,042.75View SEC Filing  
12/26/2014Ronald RichardDirectorSell5,000$28.00$140,000.00View SEC Filing  
12/17/2014Ronald RichardDirectorSell5,000$27.00$135,000.00View SEC Filing  
12/11/2014Fuad El-HibriMajor ShareholderSell119,341$26.00$3,102,866.00View SEC Filing  
11/28/2014Fuad El-HibriMajor ShareholderSell34,577$25.00$864,425.00View SEC Filing  
11/25/2014Fuad El-HibriMajor ShareholderSell9,014$25.00$225,350.00View SEC Filing  
11/25/2014Zsolt HarsanyiDirectorSell8,000$24.82$198,560.00View SEC Filing  
11/12/2014Fuad El-HibriMajor ShareholderSell2,311$25.00$57,775.00View SEC Filing  
11/7/2014Robert KramerCFOSell2,625$24.00$63,000.00View SEC Filing  
4/16/2014Robert KramerCFOSell50,189$24.34$1,221,600.26View SEC Filing  
3/12/2014Adam HaveyEVPSell11,562$27.50$317,955.00View SEC Filing  
3/11/2014Adam HaveyEVPSell17,655$26.96$475,978.80View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Emergent Biosolutions (NYSE:EBS)
DateHeadline
capitalcube.com logoEmergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : September 26, 2016 (NYSE:EBS)
www.capitalcube.com - September 26 at 9:28 AM
News Icon2 Biotech Stocks News And Price Trends: Emergent BioSolutions, Inc. (NYSE:EBS), Achillion Pharmaceuticals, Inc ... - The Voice Registrar (NYSE:EBS)
voiceregistrar.com - September 22 at 4:49 PM
4-traders.com logoInvestigation for Investors in Emergent Biosolutions Inc (NYSE:EBS) over Potential Wrongdoing by Certain Directors Announced (NYSE:EBS)
www.4-traders.com - September 22 at 10:19 AM
publicnow.com logo22.09.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Actin connection with sec. 91 art. 2 Austrian Stock Exchange Act -Changes of significant shareholdings (NYSE:EBS)
www.publicnow.com - September 22 at 10:19 AM
News IconHow Emergent BioSolutions, Inc. (NYSE:EBS) trades after earning ... - The Independent Republic (NYSE:EBS)
theindependentrepublic.com - September 21 at 5:15 PM
News Icon4700 Shares of Emergent Biosolutions Inc (EBS) Stock are sold by George A. Joulwan - DailyQuint (NYSE:EBS)
dailyquint.com - September 21 at 9:02 AM
publicnow.com logo21.09.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Actin connection with sec. 91 art. 2 Austrian Stock Exchange Act -Changes of significant shareholdings (NYSE:EBS)
www.publicnow.com - September 21 at 9:02 AM
News Icon8,699 Shares of Emergent Biosolutions Inc (EBS) Stock are sold by ... - DailyQuint (NYSE:EBS)
dailyquint.com - September 19 at 3:37 PM
News Icon2 Biotech Stocks News And Price Trends: CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD), Emergent BioSolutions, Inc ... - The Voice Registrar (NYSE:EBS)
voiceregistrar.com - September 19 at 3:37 PM
publicnow.com logo19.09.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Actin connection with sec. 91 art. 2 Austrian Stock Exchange Act -Changes of significant shareholdings (NYSE:EBS)
www.publicnow.com - September 19 at 9:24 AM
News IconEMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General & Kahn Swick & Foti, LLC Re... (NYSE:EBS)
ih.advfn.com - September 17 at 9:28 AM
businesswire.com logoEMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action ... (NYSE:EBS)
www.businesswire.com - September 17 at 9:28 AM
finance.yahoo.com logoEMERGENT 72 HOUR DEADLINE ALERT: Approximately 72 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Emergent BioSolutions, Inc. – EBS (NYSE:EBS)
finance.yahoo.com - September 17 at 9:28 AM
finance.yahoo.com logo2-DAY ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 17 at 9:28 AM
finance.yahoo.com logoUPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 - EBS (NYSE:EBS)
finance.yahoo.com - September 16 at 4:39 PM
finance.yahoo.com logoFINAL DEADLINE ALERT - - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016 (NYSE:EBS)
finance.yahoo.com - September 16 at 4:39 PM
finance.yahoo.com logoMONDAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 16 at 4:39 PM
News IconAnalyst Projections and Growth Recap for Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS)
www.kentuckypostnews.com - September 16 at 8:26 AM
finance.yahoo.com logo4-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 15 at 5:04 PM
publicnow.com logoManagement Board Changes at Erste Group and Erste Bank (NYSE:EBS)
www.publicnow.com - September 15 at 5:04 PM
News IconShort Information Review for: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS)
www.kentuckypostnews.com - September 14 at 8:54 AM
globenewswire.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action ... - GlobeNewswire (press release) (NYSE:EBS)
globenewswire.com - September 14 at 8:54 AM
finance.yahoo.com logoGPM Reminds Investors of the September 19th Deadline in the Class Action Lawsuit Against Emergent BioSolutions, Inc. and Encourages Investors to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 14 at 8:54 AM
finance.yahoo.com logoSEPTEMBER 19 DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 14 at 8:54 AM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 – EBS (NYSE:EBS)
finance.yahoo.com - September 14 at 8:54 AM
finance.yahoo.com logo6-DAY DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 14 at 8:54 AM
News IconStock Up Over the Past Five Trading Sessions: Emergent ... - Post News (NYSE:EBS)
www.kentuckypostnews.com - September 13 at 9:36 AM
finance.yahoo.com logoBrower Piven Alerts Shareholders of September 19, 2016 Deadline in Class Action Lawsuit and Encourages Those With Losses in Excess of $100,000 From Investment in Emergent BioSolutions, Inc. to Contact the Firm - EBS (NYSE:EBS)
finance.yahoo.com - September 13 at 9:36 AM
finance.yahoo.com logo7-DAY DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 13 at 9:36 AM
News IconShares Lower Over the Past Quarter: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS)
www.kentuckypostnews.com - September 11 at 9:15 AM
News IconINVESTOR ALERT Hagens Berman Reminds Emergent Biosolutions, Inc. (NYSE EBS) Investors of September 19 ... - EconoTimes (NYSE:EBS)
www.econotimes.com - September 10 at 9:20 AM
News IconWhich way Emergent BioSolutions, Inc. (NYSE:EBS) earnings may ... - The Voice Registrar (NYSE:EBS)
voiceregistrar.com - September 10 at 9:20 AM
businesswire.com logoINVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Emergent Biosolutions Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 19, 2016 (NYSE:EBS)
www.businesswire.com - September 9 at 4:36 PM
prnewswire.com logoINVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors ... (NYSE:EBS)
www.prnewswire.com - September 8 at 4:38 PM
finance.yahoo.com logoINVESTOR ALERT: Hagens Berman Reminds Emergent Biosolutions, Inc. (NYSE: EBS) Investors of September 19, 2016 Lead Plaintiff Deadline (NYSE:EBS)
finance.yahoo.com - September 8 at 4:38 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Emergent Biosolutions, Inc (EBS) & Lead Plaintiff Deadline - September 19, 2016 (NYSE:EBS)
finance.yahoo.com - September 8 at 4:38 PM
finance.yahoo.com logoDEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 8 at 4:38 PM
prnewswire.com logoINVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 ... - PR Newswire (press release) (NYSE:EBS)
www.prnewswire.com - September 7 at 4:53 PM
finance.yahoo.com logoINVESTOR ALERT: Rosen Law Firm Reminds Emergent BioSolutions, Inc. Investors of Important September 19 Deadline in Class Action - EBS (NYSE:EBS)
finance.yahoo.com - September 7 at 4:53 PM
finance.yahoo.com logoLifshitz & Miller Law Firm Announces Investigation of Accuride Corporation, Albany Molecular Research Inc., Emergent BioSolutions, Inc., Flowers Foods, Inc., Orbital ATK, Inc., Quorum Health Corp., Stericycle, Inc., and SunPower Corporation (NYSE:EBS)
finance.yahoo.com - September 7 at 4:53 PM
finance.yahoo.com logoUPCOMING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 7 at 4:53 PM
News IconShort Data Recap for: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS)
www.kentuckypostnews.com - September 7 at 8:04 AM
finance.yahoo.com logoEBS SHAREHOLDER ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Emergent Biosolutions Inc. and a Lead Plaintiff Deadline of September 19, 2016 (NYSE:EBS)
finance.yahoo.com - September 6 at 4:40 PM
capitalcube.com logoETF’s with exposure to Emergent BioSolutions, Inc. : September 6, 2016 (NYSE:EBS)
www.capitalcube.com - September 6 at 4:40 PM
finance.yahoo.com logoUPCOMING DEADLINE: Lundin Law PC Announces Securities Class Action Lawsuit against Emergent BioSolutions, Inc. and Reminds Investors with Losses to Contact the Firm (NYSE:EBS)
finance.yahoo.com - September 6 at 4:40 PM
News IconNews review of 2 biotech stocks: Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT), Emergent BioSolutions, Inc. (NYSE ... - The Voice Registrar (NYSE:EBS)
voiceregistrar.com - September 6 at 9:36 AM
News IconMedical Gases Market Size To Reach $15.1 Billion By 2024: Grand View Research, Inc. (NYSE:EBS)
www.econotimes.com - September 5 at 4:26 PM
News IconTransdermal Drug Delivery System Market Worth $81.4 Billion By 2024: Grand View Research, Inc. (NYSE:EBS)
www.econotimes.com - September 5 at 9:23 AM
News IconStock Struggling for the Quarter: Emergent BioSolutions, Inc. (NYSE:EBS) - Post News (NYSE:EBS)
www.kentuckypostnews.com - September 4 at 4:28 PM
News IconRain Design unveils mStand series for Macbook, iPad and iPhone with Apple-matching colors at IFA Sep 2016 (NYSE:EBS)
www.econotimes.com - September 4 at 9:13 AM

Social

Emergent Biosolutions (NYSE:EBS) Chart for Monday, September, 26, 2016


Last Updated on 9/26/2016 by MarketBeat.com Staff